Editorial Board — Medscape Ophthalmology
Board Members
- David M. Brown, MD
- Weill Cornell College of Medicine
Retina Consultants of Houston
Houston, Texas
- Weill Cornell College of Medicine
- David K. Coats, MD
- Baylor College of Medicine
Texas Children's Hospital
Houston, Texas
- Baylor College of Medicine
- H. Burkhard Dick, MD, PhD
- Ruhr University Eye Hospital
Bochum, Germany
- Ruhr University Eye Hospital
- Ronald C. Gentile, MD
- Icahn School of Medicine
The New York Eye and Ear Infirmary
New York, New York
- Icahn School of Medicine
- L. Jay Katz, MD
- Sidney Kimmel Medical College
Thomas Jefferson University
Wills Eye Institute
Philadelphia, Pennsylvania
- Sidney Kimmel Medical College
Board Member Details
David M. Brown, MD
![David M. Brown, MD](jpg/brown_david.jpg)
Associate Professor, Department of Ophthalmology, The Methodist Hospital, Weill Cornell College of Medicine; Director of Clinical Research, Retina Consultants of Houston, Houston, Texas
David M. Brown, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Ohr Pharmaceutical, Inc.; ChengduKanghong Biotechnology; REGENXBIO Inc.; Clearside Biomedical Inc.; Heidelberg; Optos; Carl Zeiss Meditec; Stealth Biotherapeutics; Apellis
Received research grant from: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Heidelberg; Ohr Pharmaceutical, Inc.; ThromboGenics, Inc.; REGENXBIO Inc.; Clearside Biomedical Inc.
Received income in an amount equal to or greater than $250 from: Genentech/Roche; Regeneron Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Avedrum Biotechnologies, Inc.; Santeen; Samsung; Senju; Clearside Biomedical Inc.; Heidelberg; Optos; Carl Zeiss Meditec; Ohr Pharmaceutical, Inc.; REGENEXBIO Inc.; ChengduKanghong Biotechnology; Apellis; Stealth Biotherapeutics
David K. Coats, MD
![David K. Coats, MD](jpg/hs-coats-david.jpg)
Professor, Department of Ophthalmology and Pediatrics, Baylor College of Medicine; Chief, Department of Ophthalmology, Texas Children's Hospital, Houston, Texas
David K. Coats, MD, has disclosed no relevant financial relationships.
H. Burkhard Dick, MD, PhD
![H. Burkhard Dick, MD, PhD](png/hs-dick-h-burkhard.png)
Professor and Chairman, Institute for Vision Science, Ruhr University Eye Hospital, Bochum, Germany
H. Burkhard Dick, MD, PhD, has disclosed the following relevant financial relationships:
Served as a board member (unpaid) for: Atia Medical/Shifamed, LLC; Avellino Lab USA, Inc.; Carl Zeiss Meditec; InfiniteVision Optics SAS; Medicem Group B.V.; Optical Express Inc.; Pharm-Allergan GmbH; Vivior AG; WebMD, LLC
Serve(d) as a consultant for: Avedro Inc.; Carl Zeiss Meditec; Johnson & Johnson Vision; Medicem Group B.V.; Optical Express Inc.; Polytech Domilens GmbH; RxSight, Inc.
Serve(d) as a consultant for (unpaid): AcuFocus, Inc.; Atia Medical/Shifamed, LLC; Avellino Lab USA, Inc.; Excel Lens Inc.
Received grants paid to the institution/grants pending from: AbbVie GmbH & Co. KG; AcuFocus, Inc.; Allergan GmbH; Avedro Inc.; Bayer Healthcare AG; Carl Zeiss Meditec; F. Hoffmann-La Roche Ltd; Implandata Ophthalmic Products GmbH; Johnson & Johnson Vision; Medicem Group B.V.; Novartis Pharmaceuticals Corporation GmbH; Ophtec BV; OSD Medical GmbH; Powervision, Inc.; ROWIAK GmbH; URSAPHARM Arzneimittel GmbH
Received payment for lectures including service on speakers bureau for: Johnson & Johnson Vision; Bausch + Lomb Inc.; Oculus Inc.; Pharm-Allergan GmbH; Thea Pharma GmbH
Holds patents from: Abbott; Morcher GmbH
Received royalties from: Oculus Inc.
Has stock/stock options in: AcuFocus, Inc.; Excel Lens Inc.; Implandtada Ophthalmic Products GmbH; RxSight, Inc.; Stroma Medical Corporation; Vivior Ltd.
Ronald C. Gentile, MD
Clinical Professor of Ophthalmology, Icahn School of Medicine; Co-Director, The Ocular Trauma Service, The New York Eye and Ear Infirmary, New York, New York
Ronald C. Gentile, MD, has disclosed no relevant financial relationships.
L. Jay Katz, MD
![L. Jay Katz, MD](jpg/katz_ljay.jpg)
Director Emeritus, Glaucoma Service, Wills Eye Hospital; Professor, Department of Ophthalmology, Thomas Jefferson University, Philadelphia, Pennsylvania
L. Jay Katz, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Glaukos (Chief Medical Officer)
Serve(d) as a speaker or a member of a speakers bureau for: Allergan; Bausch and Lomb; Glaukos
Received research grant from: Diopsys; Heidelberg; Zeiss
Received income in an amount equal to or greater than $250 from: Allergan; Alcon; Bausch and Lomb; Glaukos